Search results
Results from the WOW.Com Content Network
IL13RA2+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: Q14627 (Interleukin-13 receptor subunit alpha-2) at the PDBe-KB. This article incorporates text from the United States National Library of Medicine, which is in the public ...
There is also another receptor that can bind IL-13: IL-13Rα2 encoded by the IL13RA2 gene. This binds IL-13 with very high affinity (and can therefore sequester it) but does not allow IL-4 binding. It acts as a negative regulator of both IL-13 and IL-4, however the mechanism of this is still undetermined. [3]
The following is a partial list of the "E" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM). This list continues the information at List of MeSH codes (E01). Codes following these are found at List of MeSH codes (E03). For other MeSH codes, see List of MeSH codes.
A major application of cellular adoptive therapy is cancer treatment, as the immune system plays a vital role in the development and growth of cancer. [1] The primary types of cellular adoptive immunotherapies are T cell therapies. Other therapies include CAR-T therapy, CAR-NK therapy, macrophage-based immunotherapy and dendritic cell therapy.
Juno Therapeutics has an experimental anti-CD171 CAR-T therapy in development to treat Neuroblastoma. CD172a Tyrosine-protein phosphatase non-receptor type substrate 1, also known as SIRPa (Signal Regulatory Protein Alpha); acts as inhibitory transmembrane receptor with CD47 resulting in inhibition of phagocytosis ("don't eat me"), stimulation ...
Depiction of adoptive cell transfer therapy with CAR-engineered T cells. The first step in the production of CAR T-cells is the isolation of T cells from human blood. CAR T-cells may be manufactured either from the patient's own blood, known as an autologous treatment, or from the blood of a healthy donor, known as an allogeneic treatment. The ...
Engineered chimeric antigen receptor (CAR)-T cell delivery is the methodology by which clinicians introduce the cancer-targeting therapeutic system of the CAR-T cell to the human body. CAR-T cells, which utilizes genetic modification of human T-cells to contain antigen binding sequences in addition to the receptor systems CD4 or CD8 , are ...
12984 Ensembl ENSG00000100368 ENSMUSG00000071714 UniProt P32927 P26954 RefSeq (mRNA) NM_000395 NM_001287389 NM_007781 RefSeq (protein) NP_000386 NP_001274318 NP_031807 Location (UCSC) Chr 22: 36.91 – 36.94 Mb Chr 15: 78.17 – 78.19 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse CSF2RB (also known as cytokine receptor common subunit beta) is a common subunit to the following type ...